SmartNEBI will develop a sustainable, enzyme-based synthesis of heart-medicine nebivolol to enhance sustainability, scalability, and EU pharmaceutical sovereignty.
Part of the Menarini Group, Lusochimica aims to create a greener, more efficient synthesis of nebivolol, a widely used cardiovascular drug. The project will immobilise two alcohol dehydrogenase enzymes on solid support and integrate them into flow chemistry, optimising conditions at the laboratory and pilot scale. By establishing a European-based, competitive production, this initiative enhances sustainability, scalability, and pharmaceutical sovereignty.
Explore EU innovative projects awarded the STEP Seal. View projects’ details, funding status, and connect with promoters via the interactive dashboard.
Other STEP stories on digital tech
Axelera-FAST (Fueling Axelera’s Semiconductor & AI Transformation) is a project designed to scale Axelera AI up and mass-produce Europe’s first fully sovereign AI acceleration platform.
Europe’s critical infrastructure needs smarter protection. MIRAGE brings together autonomous robots, advanced sensors and AI to monitor energy sites and logistics hubs with greater precision, wider coverage and lower cost.
OpenEuroLLM will develop a family of Large Language Model (LLMs) covering all EU official languages, ensuring transparency, compliance with the AI Act, and uptake among European businesses, startups, and innovators
Discover STEP
Read more about STEP and its results
Learn about the Strategic Technologies for Europe Platform (STEP): its mission to boost EU investment in critical technologies, its scope and its synergies with 11 EU funding programmes. Driving innovation and competitiveness across Europe.
Discover innovative projects in digital, clean, bio and defence technology sectors and explore how they shape the future of innovation in Europe.
Funding allocations, STEP Seal projects, and sectoral investment trends in digital, clean-tech, and biotech. See how EU investments drive innovation and strategic autonomy.